CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities:
Net income	$ 169,899	$ 143,252	$ 88,587
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	156,668	137,865	132,043
Change in fair value of derivative instruments	(87)	1	90
Amortization of deferred losses on derivative instruments	5,066	8,548	12,896
Write-downs and other charges, net	5,992	3,713	18,314
Impairment of goodwill	0	0	5,562
Asset impairment	0	6,301	27,688
Amortization of debt discount and debt issuance costs	17,492	19,026	18,182
Interest—paid in kind	2,130	4,254	4,158
Share-based compensation	6,590	19,726	12,775
Settlement of liability-classified equity awards	(18,739)	0	0
Earnings from joint ventures	(1,913)	(809)	(924)
Distributions from joint ventures	1,334	1,686	1,877
Gain on Native American development	0	0	(49,074)
Loss on extinguishment/modification of debt	7,270	90	4,132
Changes in assets and liabilities:
Restricted cash	(225)	1,067	0
Receivables, net	(3,492)	178	(6,700)
Interest on related party notes receivable	(247)	(722)	(742)
Inventories and prepaid expenses	(303)	(2,389)	(73)
Accounts payable	8,892	4,954	2,911
Accrued interest payable	2,460	(1,461)	(1,782)
Other accrued liabilities	(271)	1,281	(3,234)
Other, net	1,472	2,879	3,105
Net cash provided by operating activities	359,988	349,440	269,791
Cash flows from investing activities:
Capital expenditures, net of related payables	(162,377)	(129,925)	(102,748)
Business acquisition, net of cash received	(305,886)	0	0
Proceeds from asset sales	11,094	26,329	2,739
Repayment (issuance) of related party note receivable	18,330	500	(500)
Investment in joint ventures	0	(327)	(6,817)
Distributions in excess of earnings from joint ventures	1,015	971	1,019
Proceeds from repayment of Native American development costs	0	0	66,048
Native American development costs	(2,704)	(1,827)	(2,630)
Other, net	(3,568)	(1,994)	2
Net cash used in investing activities	(444,096)	(106,273)	(42,887)
Cash flows from financing activities:
Borrowings under credit agreements with original maturity dates greater than three months	1,872,500	55,000	0
Payments under credit agreements with original maturities greater than three months	(1,517,547)	(82,684)	(71,129)
(Payments) borrowings under credit agreements with original maturities of three months or less, net	(53,900)	20,000	1,250
Capital contributions	419,475	0	0
Distributions to members and noncontrolling interests	(153,900)	(222,228)	(163,413)
Deemed distributions	(389,149)	0	0
Payment of debt issuance costs	(39,815)	(797)	(2,454)
Payments on derivative instruments with other-than-insignificant financing elements	(10,831)	(8,947)	(10,980)
Capital contributions from noncontrolling interests	0	0	9,969
Payments on other debt	(22,288)	(3,682)	(3,139)
Other, net	(7,101)	(6,522)	(1,772)
Net cash provided by (used in) financing activities	97,444	(249,860)	(241,668)
Cash and cash equivalents (including cash and cash equivalents of discontinued operations):
Increase (decrease) in cash and cash equivalents	13,336	(6,693)	(14,764)
Balance, beginning of year	116,623	123,316	138,080
Balance, end of year	129,959	116,623	123,316
Supplemental cash flow disclosures:
Cash paid for interest	116,314	122,103	129,090
Non-cash investing and financing activities:
Capital expenditures incurred but not yet paid	$ 21,375	$ 19,886	$ 17,360